Acute Kidney Injury Recovery Patterns in Critically Ill Patients: Results of a Retrospective Cohort Study.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
01 07 2021
Historique:
pubmed: 8 4 2021
medline: 14 9 2021
entrez: 7 4 2021
Statut: ppublish

Résumé

Acute kidney injury, acute kidney injury severity, and acute kidney injury duration are associated with both short- and long-term outcomes. Despite recent definitions, only few studies assessed pattern of renal recovery and time-dependent competing risks are usually disregarded. Our objective was to describe pattern of acute kidney injury recovery, change of transition probability over time and their risk factors. Monocenter retrospective cohort study. Acute kidney injury was defined according to Kidney Disease Improving Global Outcomes definition. Renal recovery was defined as normalization of both serum creatinine and urine output criteria. Competing risk analysis, time-inhomogeneous Markov model, and group-based trajectory modeling were performed. Monocenter study. Consecutive patients admitted in ICU from July 2018 to December 2018 were included. None. Three-hundred fifty patients were included. Acute kidney injury occurred in 166 patients at ICU admission, including 64 patients (38.6%) classified as acute kidney disease according to Acute Disease Quality Initiative definition and 44 patients (26.5%) who could not be classified. Cumulative incidence of recovery was 25 % at day 2 (95% CI, 18-32%) and 35% at day 7 (95% CI, 28-42%). After adjustment, need for mechanical ventilation (subdistribution hazard ratio, 0.42; 95% CI, 0.23-0.74) and severity of the acute kidney injury (stage 3 vs stage 1 subdistribution hazard ratio, 0.11; 95% CI, 0.03-0.35) were associated with lack of recovery. Group-based trajectory modeling identified three clusters of temporal changes in this setting, associated with both acute kidney injury recovery and patients' outcomes. In this study, we demonstrate Acute Disease Quality Initiative to allow recovery pattern classification in 75% of critically ill patients. Our study underlines the need to take into account competing risk factors when assessing recovery pattern in critically ill patients.

Identifiants

pubmed: 33826581
doi: 10.1097/CCM.0000000000005008
pii: 00003246-202107000-00033
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e683-e692

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Déclaration de conflit d'intérêts

Dr. Mariotte reports personal fees from Sanofi outside the submitted work. Dr. Valade reports personal fees for teaching from Sanofi and Gilead, “invitation to congress” from Pfizer, and personal fees from PR editions for expert opinion outside the submitted work. Dr. Zafrani’s institution received funding from Jazz Pharmaceuticals outside the submitted work. Dr. Azoulay has received fees for lectures from Gilead, Pfizer, Baxter, and Alexion, and his research group has been supported by Ablynx, Fisher & Paykel, Jazz Pharma, and MSD. Dr. Darmon declares having received a grant from MSD, speaker fees from MSD, Astellas, and Gilead-Kite and having attended an advisory board for Gilead-Kite. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Références

Schetz M, Darmon M. Measuring acute kidney injury around the world: Are we using the right thermometer (and adequately)? Intensive Care Med. 2015; 41:1857–1859
Nisula S, Kaukonen KM, Vaara ST, et al.; FINNAKI Study Group. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: The FINNAKI study. Intensive Care Med. 2013; 39:420–428
Kellum JA, Sileanu FE, Murugan R, et al. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015; 26:2231–2238
Vaara ST, Pettilä V, Kaukonen KM, et al.; Finnish Acute Kidney Injury Study Group. The attributable mortality of acute kidney injury: A sequentially matched analysis*. Crit Care Med. 2014; 42:878–885
Wu VC, Wu CH, Huang TM, et al.; NSARF Group. Long-term risk of coronary events after AKI. J Am Soc Nephrol. 2014; 25:595–605
Sawhney S, Marks A, Fluck N, et al. Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions. BMC Nephrol. 2017; 18:9
Bagshaw SM, Darmon M, Ostermann M, et al. Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury. Intensive Care Med. 2017; 43:841–854
Forni LG, Darmon M, Ostermann M, et al. Renal recovery after acute kidney injury. Intensive Care Med. 2017; 43:855–866
Heung M, Steffick DE, Zivin K, et al.; Centers for Disease Control and Prevention CKD Surveillance Team. Acute kidney injury recovery pattern and subsequent risk of CKD: An analysis of veterans health administration data. Am J Kidney Dis. 2016; 67:742–752
Bucaloiu ID, Kirchner HL, Norfolk ER, et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 2012; 81:477–485
Kellum JA, Sileanu FE, Bihorac A, et al. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017; 195:784–791
Truche AS, Ragey SP, Souweine B, et al. ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients. Ann Intensive Care. 2018; 8:127
Perinel S, Vincent F, Lautrette A, et al. Transient and persistent acute kidney injury and the risk of hospital mortality in critically ill patients: Results of a multicenter cohort study. Crit Care Med. 2015; 43:e269–e275
Uhel F, Peters-Sengers H, Falahi F, et al.; MARS consortium. Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: A prospective cohort study. Intensive Care Med. 2020; 46:1576–1589
Sharma A, Mucino MJ, Ronco C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract. 2014; 127:94–100
Chawla LS, Amdur RL, Shaw AD, et al. Association between AKI and long-term renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol. 2014; 9:448–456
Chawla LS, Amdur RL, Amodeo S, et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 2011; 79:1361–1369
Schetz M, Gunst J, De Vlieger G, et al. Recovery from AKI in the critically ill: Potential confounders in the evaluation. Intensive Care Med. 2015; 41:1648–1657
Chawla LS, Bellomo R, Bihorac A, et al.; Acute Disease Quality Initiative Workgroup 16. Acute kidney disease and renal recovery: Consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017; 13:241–257
Palevsky PM, Molitoris BA, Okusa MD, et al. Design of clinical trials in acute kidney injury: Report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012; 7:844–850
Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1). Crit Care. 2013; 17:204
Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158:825–830
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801–810
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22:707–710
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94:496–509
Allignol A, Schumacher M, Beyersmann J. Empirical transition matrix of multi-state models: The etm package. J Stat Soft. 2011; 38:1–15
Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010; 6:109–138
Genolini C, Falissard B. KmL: A package to cluster longitudinal data. Comput Methods Programs Biomed. 2011; 104:e112–e121
Elsensohn MH, Klich A, Ecochard R, et al. A graphical method to assess distribution assumption in group-based trajectory models. Stat Methods Med Res. 2016; 25:968–982
Zabor EC, Furberg H, Mashni J, et al. Factors associated with recovery of renal function following radical nephrectomy for kidney neoplasms. Clin J Am Soc Nephrol. 2016; 11:101–107
Zabor EC, Furberg H, Lee B, et al. Long-term renal function recovery following radical nephrectomy for kidney cancer: Results from a multicenter confirmatory study. J Urol. 2018; 199:921–926
Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res. 2007; 13:559–565
Fiorentino M, Tohme FA, Wang S, et al. Long-term survival in patients with septic acute kidney injury is strongly influenced by renal recovery. PLoS One. 2018; 13:e0198269
Pannu N, James M, Hemmelgarn B, et al.; Alberta Kidney Disease Network. Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol. 2013; 8:194–202
Pannu N, James M, Hemmelgarn BR, et al.; Alberta Kidney Disease Network. Modification of outcomes after acute kidney injury by the presence of CKD. Am J Kidney Dis. 2011; 58:206–213
Schetz M, Gunst J, Van den Berghe G. The impact of using estimated GFR versus creatinine clearance on the evaluation of recovery from acute kidney injury in the ICU. Intensive Care Med. 2014; 40:1709–1717
Sautenet B, Caille A, Giraudeau B, et al. Deficits in information transfer between hospital-based and primary-care physicians, the case of kidney disease: A cross-sectional study. J Nephrol. 2015; 28:563–570
Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med. 2015; 41:1411–1423

Auteurs

Moustafa Abdel-Nabey (M)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.

Etienne Ghrenassia (E)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.

Eric Mariotte (E)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.

Sandrine Valade (S)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.

Guillaume Morel (G)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.

Virginie Lemiale (V)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.

Lara Zafrani (L)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.

Elie Azoulay (E)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.
ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153 (Center of Epidemiology and Biostatistics Sorbonne Paris Cité, CRESS), INSERM, Paris, France.

Michael Darmon (M)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
Medicine University, Paris 5 University, Paris, France.
ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153 (Center of Epidemiology and Biostatistics Sorbonne Paris Cité, CRESS), INSERM, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH